In vitro effects of MOCA and dapsone on rat hepatic and splenic immune cells

Immunopharmacology

Volumn 35, Issue 3, 1997, Pages 183-193

  Kelso, Joanne M ^a   Cheng Long, Bai ^a,b   Ahokas, Jorma T ^a   Wright, Paul F A ^a  

^a RMIT UNIVERSITY   (Australia)

^b National Institute of Occupational Health and Safety   (Australia)

Author keywords

cytotoxicity; dapsone; immunotoxicity; mitogenesis; MOCA; natural immunity

Indexed keywords

4,4' METHYLENEBIS(2 CHLOROANILINE); AROMATIC AMINE; CARCINOGEN; DAPSONE; MITOGENIC AGENT; MUTAGENIC AGENT;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CARCINOGENICITY; CELL MEDIATED CYTOTOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; IMMUNOTOXICITY; LIVER CELL; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MALE; MITOGENESIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; T LYMPHOCYTE; TUMOR CELL;

ANIMALS; ANTI-INFECTIVE AGENTS; B-LYMPHOCYTES; CARCINOGENS; CELL SURVIVAL; DAPSONE; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE ACTIVATION; MALE; METHYLENEBIS(CHLOROANILINE); MICE; MICE, INBRED BALB C; MICE, INBRED DBA; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; T-LYMPHOCYTES;

EID: 0031055046     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(96)00146-4     Document Type: Article

References (33)

1. American Conference of Governmental Industrial Hygienists. Documentation of Threshold Limit Values for the American Conference of Governmental Industrial Hygienists. CAS 101-14-4 1992; 988-994.
2. 35S] dapsone and its metabolites in the urine, faeces and bile of the rat. Xenobiotica 1974; 4: 571-583.
3. Barnes JR. Toxicity study on MOCA 4,4′-Methylene bis(2-chloroaniline). El du Pont de Nemours and Co., Newark, DE, 1964.
4. Cocker J, Boobis AR, Wilson H, Gompertz D. Evidence that a N-glucuronide of 4,4′-Methylene bis(2-chloroaniline) (MBOCA) is a major urinary metabolite in man: Implications for biological monitoring. Br J Ind Med 1990; 47: 154-161.
5. Dean JH and Murray MI. Toxic responses of the immune system, in Amdur MO, Doull J, Klaassen CD (eds): Casarett and Doull's Toxicology: The Basic Science of Poisons. New York, Pergamon Press Inc, 1991, 4th ed, pp 282-333.
6. Edwards JW and Priestly BG. Biological and biological effect monitoring of workers exposed to 4,4′-methylene bis(2-chloroaniline). Hum Exp Toxicol 1992; 11: 229-236.
7. Farmer PB, Rickard J, Robertson S. The metabolism and distribution of 4,4′-Methylene bis(2-chloroaniline) (MBOCA) in rats. J Appl Toxicol 1981; 1: 317-322.
8. Gierade PM, Lanman R, Gaudebout C, Olivares R, Saimot AG, Jelazko P, Gaudebout C, Certain A, Boue F, Bouvet E, Lecompte T, Coulaud JP. Dapsone-pyrimethamine compared with aerodized pentamidine as primary prophylaxis against pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. New Engl J Med 1993; 328: 1514-1520.
9. Griciute L and Tomatis L. Carcinogenicity of dapsone in mice and rats. Int J Cancer 1980; 25: 123-129.
10. Grosman SJ, Simson J, Jollow DJ. Dapsone induced haemolytic anaemia: Effect of N-hydroxydapsone on the sulfhydryl status and membrane proteins of rat erythrocytes. Toxicol Appl Pharmacol 1992; 117: 208-217.
11. Harvey SC. Antimicrobial drugs, in Osol A (ed): Remington's Pharmaceutical Sciences. Easton, Mack Publishing Co, 1975, 15th ed, pp 1150-1151.
12. Hosein HR and Van Roosmalen PB. Summary report: Acute exposure to methylene-bis-chloroaniline (MOCA). Am Ind Hyg Assoc J 1978; 39: 496-497.
13. IARC. IARC Monograph on the evaluation of the carcinogenic risk of chemicals to humans. Lyon, France, 1980, vol 24.
14. IARC. IARC Monograph on the evaluation of carcinogenic risks to humans. Lyon, France, 1987, vol 1-42 (Suppl 7).
15. IARC. IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon, France, 1993, vol 57.
16. Kennedy GL. Inhalation toxicology, in Hayes AW (ed): Principles and Methods of Toxicology. New York, Raven Press, 1989, 2nd ed., pp. 361-382.
17. Kugler-Steigmeier ME, Friederich V, Graf U, Lutz WK, Maier P, Schlatter C. Genotoxicity of aniline derivatives in various short-term tests. Mutat Res 1989; 211: 279-289.
18. Leung KH, Salazar D, Cohen S. Characterisation of natural cytotoxic effector cells isolated from rat liver. Nat Immun Cell Growth Regul 1987; 6: 150-160.
19. Luster MI, Portier C, Pait DG, White KL, Gennings C, Munson AE, Rosenthal GJ. Risk assessment in immunotoxicology: 1. Sensitivity and predictability of immune tests. Fundam Appl Toxicol 1992; 18: 200-210.
20. McQueen CA and Williams GM. Review of the genotoxicity and carcinogenicity of 4,4′-Methylene dianiline and 4,4′-Methylene bis(2-chloroaniline). Mutat Res 1990; 239: 133-42.
21. Malter M, Freidrick E, Suss R. Liver as a tumour cell killing organ. Kupffer cells and natural killers. Cancer Res 1986; 46: 3055.
22. Mandell GL and Sande MA. Antimicrobial agents: Drugs used in the chemotherapy of tuberculosis and leprosy, in Gilman AG, Goodman LS, Gilman A, (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York, MacMillan Publishing Co Inc, 1980, 6th ed, pp 1200-1221.
23. National Cancer Institute. Bioassay of dapsone for possible carcinogenicity. Technical Report Series No 20, Publ No 77-820, Washington, US Department of Health, 1977.
24. National Toxicology Program. NTP Report on the immunotoxicity of dapsone (Cas No 80-08-0) in female C57BL/6 Mice (Immune modulation studies). Technical Report No 80-08-0, Research Triangle Park, US Public Health Service, 1994.
25. Peters JH, Gordon GR, Simmon VF, Tanaka W. Mutagenesis of dapsone and its derivatives in Salmonella typhimurium. Fed Proc 1978; 37: 450.
26. Peters JH and Levy L. Dapsone acetylation in man: Another example of polymorphic acetylation. Annu NY Acad Sci 1971; 179: 660-666.
27. Schlichting LM, Wright PFA, Stacey NH. Effects of tetrachloroethylene on hepatic and splenic lymphocytotoxic activities in rodents. Toxicol Ind Health 1992; 8: 255-266.
28. Thomas WD, Craig GK, Stacey NK. Effects of chlordimeform and its metabolite 4-chloro-o-toluidine on rat splenic T, B and tumourical effector cells. Immunol Pharmac 1990; 19: 79-86.
29. Vehleke H. N-hydroxylation. Xenobiotica 1971; 1: 327-328.
30. Ward E, Halperin W, Thun M, Gossman HB, Fink B, Koss L, Osorio A, Shulte P. Bladder tumours in two young male occupationally exposed to MBOCA. Am J Ind Med 1988; 14: 267-272.
31. Wright PFA and Stacey NH. A species/strain comparison of hepatic natural lymphocytotoxic activities in rats and mice. Carcinogenesis 1991; 12: 1365-1370.
32. Wright PFA, Thomas WD, Stacey NH. Effects of trichloroethylene on hepatic and splenic lymphocytotoxic activities in rodents. Toxicology 1991; 70: 231-242.
33. Wu K, Leslie CL, Stacey NH. Effects of mutagenic and non-mutagenic aniline derivatives on rat liver drug-metabolising enzymes. Xenobiotica 1989; 11: 1275-1283.